Gjør som tusenvis av andre bokelskere
Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.
Ved å abonnere godtar du vår personvernerklæring.Du kan når som helst melde deg av våre nyhetsbrev.
This is a real-life story of a woman who turned around the tornado of cancer not once but twice, and is putting all her zeal and gusto to fight this demon the third time. And all of this, with an all-embracing smile, a mountain of daring and an infectious charisma. She has been brave, bold, and beautiful through these 6 years, and not for a moment, has she let anyone realize - there is a monstrous tumour inside of her.
Going through the stories of each of the entrepreneur's profile in the book, what also struck me was the sheer range of the startups from healthy eating to quirky products to bargain solutions to anti-virus software, the products conceived, devised, and developed span a wide canvas. While some are completely new to the market, others have taken on competition from already existing similar products, which they have managed to counter simply by making theirs a better and more user-friendly version. This again brings home yet another tried and tested rule that however crowded the marketplace is, there is always room for quality. This is also precisely why in a market overcrowded with books on entrepreneurship, you will soon see why this one flies off the shelves with such ease.Finally, I would like to point out that while at the outset this book may seem like a perfect guide for those wanting to get into start-ups and looking for viable ways of funding, it's as much a treasured read for investors wanting to put their money into sound ventures. The book enables one to get a detailed insight into what works and what doesn't in the market. Too often one tends to reject ideas that look untenable and, hence, un-fundable, and then much to the anguish of those who first rejected it, they turn out to be veritable blockbusters! Haven't we all heard of Facebook rejecting WhatsApp cofounder Brian Acton for a job and then paying $19 billion to buy what could have been its own homegrown product?
Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.
Ved å abonnere godtar du vår personvernerklæring.